Pursuant to Rule 416 under the Securities Act of 1933, as amended (the Securities Act), this ☐Ĭommon Stock, $0.0001 par value per share If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition periodįor complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. See the definitions of large acceleratedįiler, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act. The registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
(Name, address, including zip code, and telephone number, including area code, 2022 Stock Option and Incentive PlanĪmylyx Pharmaceuticals, Inc. 2015 Stock Option and Restricted Stock PlanĪmylyx Pharmaceuticals, Inc. (Address, including zip code and telephone number, including area code, of Registrants principal executive offices)Īmylyx Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on January 12, 2022
0 kommentar(er)
